Vaccines for prevention of cysticercosis.
Neurocysticercosis due to Taenia solium infection is an important cause of human morbidity and mortality. Despite the availability of effective anthelmintics, the disease remains prevalent in many parts of the world and there is a need for new and improved measures for control of the infection. An effective vaccine to prevent infection in pigs, the parasite's natural intermediate host, would be a valuable new option to assist with T. solium control. Several approaches are being used currently towards the development of a T. solium vaccine and these approaches are reviewed briefly, with emphasis on the use of recombinant oncosphere antigens. Highly effective vaccines have been developed against cysticercosis in sheep and cattle caused by Taenia ovis and Taenia saginata, respectively. This success has encouraged the adoption of a similar strategy for T. solium. The recent finding that one oncosphere antigen, TSOL18, can induce complete protection against T. solium infection in pigs, highlights the potential for development of a practical vaccine. A vision is proposed for the development of a safe, effective, inexpensive vaccine for pigs, which can be administered in an edible form. Through an international collaborative effort, research is progressing towards the realisation of such a vaccine and its use to reduce the global burden of neurocysticercosis.
Lightowlers
M W
MW
Molecular Parasitology Laboratory, Veterinary Clinical Centre, The University of Melbourne, 250 Princes Highway, Victoria 3030, Werribee, Australia. marshall@unimelb.edu.au
D000818:Animals; D000947:Antigens, Helminth / Q000096:biosynthesis; D002417:Cattle; D003551:Cysticercosis / Q000517:prevention & control / Q000662:veterinary*; D003552:Cysticercus / Q000276:immunology; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000627:therapeutic use; D012756:Sheep; D034421:Sus scrofa / Q000469:parasitology*; D013553:Swine Diseases / Q000469:parasitology / Q000517:prevention & control*; D041201:Taenia solium / Q000276:immunology*; D014612:Vaccines; D014614:Vaccines, Synthetic
D000947:Antigens, Helminth; D011994:Recombinant Proteins; D014612:Vaccines; D014614:Vaccines, Synthetic